The flu has ramped up in time for Christmas, the head of the U.S. Centers for Disease Control and Prevention said. Just last week, the CDC said the flu season was off to a slow start, but all that changed a couple of days ago when the number of reported cases rose to the point where the flu season is officially underway, said CDC Director Dr. Robert Redfield.
All news from Health Policy in India
A live vaccine genetically engineered from a common measles vaccine promises to be effective against the chikungunya virus. Such is the central finding of a recently completed Phase II trial now published in the prestigious journal "The Lancet".
A new compound that inhibits the replication of hepatitis C virus (HCV) in several stages of its lifecycle – and is capable of acting on bacteria, fungi, and cancer cells – has been synthesized by researchers at São Paulo State University (UNESP) in Brazil
None of the European Union (EU) Member States Demonstrate That They Could reach the EU target of 75% influenza vaccination coverage for vulnerable groups , According to a new report from the European Center for Disease Prevention and Control (ECDC) .
An Osaka University-led research team has developed a system for simply and inhuman producing norovirus. By coaxing human induced pluripotent stem cells (iPSCs) to develop into the type of cell that usually leads to the intestine, how can they be used for producing the virus, how can it interact with human cells, and investigating potential vaccines?
Researchers have developed genetically modified pigs that are protected from classical swine fever virus.
Point-of-care influenza testing in emergency departments reduces chest x-rays and blood tests but not antibiotic use, according to a systematic review.
When Houaida Mabrouk heard about a government campaign that offers free hepatitis C screenings , she hesitated, afraid of testing positive. But after many from her community started visiting health clinics to get checked, she changed her mind.
The US Food and Drug Administration (FDA) has approved a new diagnostic test to help detect cytomegalovirus (CMV) in newborns younger than 21 days old.
A new study has been launched in Burkina Faso for Bharat Biotech's typhoid conjugate vaccine (TCV). It is the second clinical study underway in Africa for the vaccine and the first in West Africa. The vaccine study is a joint effort by the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine, (UMSOM) and Groupe de Recherche Action en Santé (GRAS) in Burkina Faso.